Erratum to: The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines (Endocrine, (2015), 50, (212-222), 10.1007/s12020-014-0484-7);The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines

Endocrine

Volumn 50, Issue 1, 2015, Pages 212-222

  Ilisso, Concetta Paola ^a   Castellano, Maria ^a   Zappavigna, Silvia ^a   Lombardi, Angela ^a   Vitale, Giovanni ^b   Dicitore, Alessandra ^b   Cacciapuoti, Giovanna ^a   Caraglia, Michele ^a   Porcelli, Marina ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cytotoxicity; Doxorubicin; Drug combination; Hormone dependent breast cancer cell line CG5; S adenosylmethionine

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; DOXORUBICIN; FAS ANTIGEN; FAS LIGAND; S ADENOSYLMETHIONINE; ANTINEOPLASTIC ANTIBIOTIC;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CALCULATION; CANCER CELL; CELL PROLIFERATION; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVATION; FLUORESCENCE ACTIVATED CELL SORTING; GROWTH INHIBITION; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; MCF 7 CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BREAST NEOPLASMS; DRUG EFFECTS; HEALTH CARE FACILITY; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOXORUBICIN; DRUG SYNERGISM; HUMANS; S-ADENOSYLMETHIONINE; TISSUE BANKS;

EID: 84938911472     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-016-1001-y     Document Type: Erratum

References (44)

1. L. Giacinti, P.P. Claudio, M. Lopez, A. Giordano, Epigenetic information and estrogen receptor alpha expression in breast cancer. Oncologist 11, 1–8 (2006)
2. W.L. McGuire, Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin. Oncol. 5, 428–433 (1978)
3. X. Yang, D.L. Phillips, A.T. Ferguson, W.G. Nelson, J.G. Herman et al., Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Cancer Res. 61, 7025–7029 (2001)
4. R.G. Lapidus, S.J. Nass, N.E. Davidson, The loss of estrogen and progesterone receptor gene expression in human breast cancer. J Mammary Gland Biol. Neoplasia. 3, 85–94 (1998)
5. M. Widschwendter, P.A. Jones, DNA methylation and breast carcinogenesis. Oncogene 21, 5462–5482 (2002)
6. K. Polyak, Breast cancer: origins and evolution. J. Clin. Invest. 117, 3155–3163 (2007)
7. R.G. Lapidus, S.J. Nass, K.A. Butash, F.F. Parl, S.A. Weitzman et al., Mapping of ER gene CpG island methylation-specific polymerase chain reaction. Cancer Res. 58, 2515–2519 (1998)
8. A.P. Bird, CpG-rich islands and the function of DNA methylation. Nature 321, 209–213 (1986)
9. M. Fontecave, M. Atta, E. Mulliez, S-Adenosylmethionine: nothing goes to waste. Trends Biochem. Sci. 29, 243–249 (2004)
10. G.L. Cantoni, Biological methylation: selected aspects. Annu. Rev. Biochem. 44, 435–451 (1975)
11. J.M. Mato, F.J. Corrales, S.C. Lu, M.A. Avila, S-Adenosylmethionine: a control switch that regulates liver function. FASEB J. 16, 15–26 (2002)
12. S.C. Lu, J.M. Mato, Role of methionine adenosyltrasferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol 35, 227–234 (2005)
13. M. Porcelli, G. Cacciapuoti, M. Cartenì-Farina, A. Gambacorta, S-Adenosylmethionine synthetase in the thermophilic archaebacterium Sulfolobus solfataricus. Purification and characterization of two isoforms. Eur. J. Biochem. 177, 273–280 (1988)
14. P. Chiang, R.K. Gordon, J. Tal, G.C. Zeng, B.P. Doctor, K. Pardhasaradhi, P.P. McCann, S-Adenosylmethionine and methylation. FASEB J. 10, 471–480 (1996)
15. A.W. Struck, M.L. Thompson, L.S. Wong, J. Micklefield, S-Adenosylmethionine-dependent methyltransferases: highly versatile enzymes in biocatalysis, biosynthesis and other biotechnological applications. ChemBioChem 13, 2642–2655 (2012)
16. S.C. Lu, Regulation of glutathione synthesis. Mol. Asp. Med. 30, 42–59 (2009)
17. A.E. Pegg, Recent advances in the biochemistry of polyamines in eukaryotes. Biochem. J. 234, 249–262 (1986)
18. P.A. Frey, A.D. Hegeman, F.J. Ruzicka, The radical SAM superfamily. Crit. Rev. Biochem. Mol. Biol. 43, 63–88 (2008)
19. M. Sauter, B. Moffatt, M.C. Saechao, R. Hell, M. Wirtz, Methionine salvage and S-adenosylmethionine: essential links between sulfur, ethylene and polyamine biosynthesis. Biochem. J. 451, 145–154 (2013)
20. T. Bottiglieri, S-Adenosyl-l-methionine (SAMe): from the bench to the bedside-molecular basis of a pleiotropic molecule. Am. J. Clin. Nutr. 76, 1151S–1157S (2002)
21. G.I. Papakostas, C.F. Cassiello, N. Iovieno, Folates and S-adenosylmethionine for major depressive disorder. Can. J. Psychiatry 57, 406–413 (2012)
22. K.L. Soeken, W.L. Lee, R.B. Bausell, M. Agelli, B.M. Berman, Safety and efficacy of S-adenosylmethionine (SAMe) for osteoarthritis. J. Farm. Pract. 51, 425–430 (2012)
23. L. Gomez-Santos, M. Vazquez-Chantada, J.M. Mato, M.L. Martinez-Chantar, SAMe and HuR in liver physiology: usefulness of stem cells in hepatic differentiation research. Methods Mol. Biol. 826, 133–149 (2012)
24. Q.M. Anstee, C.P. Day, S-Adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility. J. Hepatol. 57, 1097–1109 (2012)
25. S.C. Lu, J.M. Mato, S-Adenosylmethionine in liver health, injury, and cancer. Physiol. Rev. 92, 1515–1542 (2012)
26. J.M. Mato, M.L. Martinez-Chantar, S.C. Lu, S-Adenosylmethionine metabolism and liver disease. Ann. Hepatol. 12, 183–189 (2013)
27. N.M. Martinez-Lopez, M.V. Valera-Rey, U. Ariz, N. Embade, M.V. Vazquez-Chantada, D.F. Fernandez-Ramos, L.G. Gomez-Santos, S.C. Lu, M.L.M. Martinez-Chantar, S-Adenosylmethionine and proliferation: new pathways, new targets. Biochem. Soc. Trans. 36, 848–852 (2008)
28. T.W.H. Li, H. Yang, H. Peng, M. Xia, J.M. Mato, S.C. Lu, Effects of S-adenosylmethionine and metylthioadenosine on inflammation-induced colon cancer in mice. Carcinogenesis 33, 427–435 (2012)
29. E. Ansorena, E.R. García-Trevijano, M.L. Martínez-Chantar, Z.Z. Huang, L. Chen, J.M. Mato, M. Iraburu, S.C. Lu, M.A. Avila, S-Adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells. Hepatology 35, 274–280 (2002)
30. Z. Hussian, M.I. Khan, M. Shahid, F.N. Almajhdi, S-Adenosylmethionine, a methyl donor, up regulates tissue inhibitor of metalloproteinase-2 in colorectal cancer. Genet. Mol. Res. 12, 1106–1118 (2013)
31. L. Chen, Y. Zeng, H. Yang, T.D. Lee, S.W. French, F.J. Corrales, E.R. García-Trevijano, M.A. Avila, J.M. Mato, S.C. Lu, Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A. FASEB J. 18, 914–916 (2004)
32. H. Chen, M. Xia, M. Lin, H. Yang, J. Kuhlenkamp, T. Li, N.M. Sodir, Y.H. Chen, H. Josef-Lenz, P.W. Laird, S. Clarke, J.M. Mato, S.C. Lu, Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells. Gastroenterology 133, 207–218 (2007)
33. T.W. Li, Q. Zhang, P. Oh, M. Xia, H. Chen, S. Bemanian, N. Lastra, M. Circ, M.P. Moyer, J.M. Mato, T.Y. Aw, S.C. Lu, S-Adenosylmethionine and methylthioadenosine inhibit cellular FLICE inhibitory protein expression and induce apoptosis in colon cancer cells. Mol. Pharmacol. 76, 192–200 (2009)
34. T.C. Chou, P. Talalay, Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22, 27–55 (1984)
35. T.C. Chou, R.J. Motzer, Y. Tong, G.J. Bosl, Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design. J. Natl Cancer Inst. 86, 1517–1524 (1994)
36. M. Lamberti, S. Porto, M. Marra, S. Zappavigna, A. Grimaldi, D. Feola, D. Pesce, S. Naviglio, A. Spina, N. Sannolo, M. Caraglia, 5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. J. Exp. Clin. Cancer. Res. 31, 60–68 (2012)
37. A. Morana, P. Stiuso, G. Colonna, M. Lamberti, M. Cartenì, M. De Rosa, Stabilization of S-adenosyl-l-methionine promoted by trehalose. Biochim. Biophys. Acta 1573, 105–108 (2002)
38. Z. Song, T. Chen, I.V. Deaciuc, S. Uriarte, D. Hill, S. Barve, C.J. McCain, Modulation of endotoxin stimulated interleukin-6 production in monocytes and kupffer cells by S-adenosylmethionine (SAMe). Cytokine 28, 214–223 (2004)
39. D.R. Barpe, D.D. Rosa, P.E. Froehlich, Pharmacokinetic evaluation of doxorubicin plasma levels in normal and overweight patients with breast cancer and simulation of dose adjustment by different indexes of body mass. Eur. J. Pharm. Sci. 41(3–4), 458–463 (2010)
40. J. Yasunaga, Y. Taniguchi, K. Nosak, M. Yoshida, Y. Satou, T. Sakai, H. Mitsuya, M. Matsuoka, Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res. 64, 6002–6009 (2004)
41. F. Chiz, Z. Machnes, M. Szyf, Synergistic anti breast cancer effect of combined treatment with the methyl donor S-adenosyl methionine (SAM) with the DNA methylation inhibitor 5-aza-2′-deoxycytidine. Carcinogenesis 35, 138–144 (2014)
42. P. Lipponen, T. Pietilainen, V.M. Kosma, S. Aaltomaa, M. Eskelinen, K. Syrjanen, Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J. Pathol. 177, 49–55 (1995)
43. S.J. Dawson, N. Makretsov, F.M. Blows, K.E. Driver, E. Provenzano, J. Le Quesne et al., BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received. Br. J. Cancer 103, 668–675 (2010)
44. B. Perillo, A. Sasso, C. Abbondanza, Palumbo G 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol. Cell. Biol. 20, 2890–2901 (2000)